ОПТИМИЗАЦИЯ ТЕРАПИИ ГАСТРОЭЗОФАГЕАЛЬНОЙ РЕФЛЮКСНОЙ БОЛЕЗНИ ПРИ КОМОРБИДНОСТИ С ФУНКЦИОНАЛЬНОЙ ДИСПЕПСИЕЙ

Каримов М.М., Зуфаров П.С., Собирова Г.Н., Исмаилова Ж.А., Дусанова Н.М.

dc.contributor.author	Каримов М.М., Зуфаров П.С., Собирова Г.Н., Исмаилова Ж.А., Дусанова Н.М.
dc.date.accessioned	2023-01-12T03:27:22Z
dc.date.available	2023-01-12T03:27:22Z
dc.date.issued	2022
dc.identifier.issn	2181-5887
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/5741
dc.description.abstract	It has been shown that in patients with GERD and functional dyspepsia, the use of proton pump inhibitors leads to a decrease in heartburn and pain behind the sternum. However, symptoms such as regurgitation, belching, feeling of early satiety and heaviness after eating were stopped ineffectively. The inclusion in the treatment complex of the prokinetic domperidone at a dose of 10 mg 3 times a day contributed to a more effective regression of symptoms of impaired motility of the esophagus and stomach.	en_US
dc.language.iso	other	en_US
dc.publisher	Терапевтический вестникм Узбекистана	en_US
dc.relation.ispartofseries	;УДК: 616.33-002.44-615.831-085.2
dc.subject	gastroesophageal reflux disease, functional dyspepsia, proton pump inhibitors, prokinetics	en_US
dc.title	ОПТИМИЗАЦИЯ ТЕРАПИИ ГАСТРОЭЗОФАГЕАЛЬНОЙ РЕФЛЮКСНОЙ БОЛЕЗНИ ПРИ КОМОРБИДНОСТИ С ФУНКЦИОНАЛЬНОЙ ДИСПЕПСИЕЙ	en_US
dc.type	Article	en_US